| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3186002 | Annales de Dermatologie et de Vénéréologie | 2014 | 7 Pages |
Abstract
Based on published studies and the results of the present study, oral isotretinoin at a dose of 0.75Â mg/kg/day may be proposed as first-line treatment for DCS.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
C. Koudoukpo, S. Abdennader, B. Cavelier-Balloy, C. Gasnier, H. Yédomon,